Close

Cancer Genetics (CGIX) Actively Testing, Providing Data for 12 IO Clinical Trials, 3 Academic Collaborations

May 4, 2016 9:30 AM EDT Send to a Friend
Cancer Genetics, Inc. (Nasdaq: CGIX) announced that the company is actively testing and providing data for 12 Immuno-Oncology (IO) clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login